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Summary
The connection of the coronary vasculature to the aorta is one of the last essential steps of cardiac
development. However, little is known about the signaling events that promote normal coronary
artery formation. The bone morphogenetic protein (BMP) signaling pathway regulates multiple
aspects of endothelial cell biology but has not been specifically implicated in coronary vascular
development. BMP signaling is tightly regulated by numerous factors, including BMP-binding
endothelial cell precursor-derived regulator (BMPER), which can both promote and repress BMP
signaling activity. In the embryonic heart, BMPER expression is limited to the endothelial cells
and the endothelial-derived cushions, suggesting that BMPER may play a role in coronary
vascular development. Histological analysis of BMPER−/− embryos at early embryonic stages
demonstrates that commencement of coronary plexus differentiation is normal and that endothelial
apoptosis and cell proliferation are unaffected in BMPER−/− embryos compared with wild-type
embryos. However, analysis between embryonic days 15.5-17.5 reveals that, in BMPER−/−
embryos, coronary arteries are either atretic or connected distal to the semilunar valves. In vitro
tubulogenesis assays indicate that isolated BMPER−/− endothelial cells have impaired tube
formation and migratory ability compared with wild-type endothelial cells, suggesting that these
defects may lead to the observed coronary artery anomalies seen in BMPER−/− embryos.
Additionally, recombinant BMPER promotes wild-type ventricular endothelial migration in a
dose-dependent manner, with a low concentration promoting and high concentrations inhibiting
migration. Together, these results indicate that BMPER-regulated BMP signaling is critical for
coronary plexus remodeling and normal coronary artery development.
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During early heart development, simple diffusion of blood is sufficient to supply the heart
with nutrients and oxygen. As the heart remodels, however, the coronary vasculature must
develop to support the oxygen and nutrient needs of a larger, more muscular heart. A wide
range of coronary anomalies have been documented, consisting of both severe (a failure of
the coronary vasculature to connect to the aorta) and less severe (abnormal locations and
numbers of coronary stems and irregular branching patterns) anomalies (Angelini, 2002). It
comes as no surprise that the absence of both coronary arteries has clearly deleterious effects
on the developing organism; however, even less severe anomalies can lead to sudden death
(Maron, 2003; Turkmen et al., 2007), illustrating the need for a comprehensive
understanding of the mechanisms and pathways involved in the development of the coronary
vasculature.
The coronary vasculature begins forming before the heart has fully septated and connects to
the aorta long after the heart has begun beating (Bernanke and Velkey, 2002). The coronary
vasculature begins as a plexus of endothelial cells that spread from the sinus venosus to
encompass the ventricles (Lavine et al., 2006; Red-Horse et al., 2010). These endothelial
cells derive from the proepicardium and traverse through the sinus venosus to yield the
subepicardial venous plexus and the intramyocardial arterial plexus (Red-Horse et al., 2010;
Katz et al., 2012; Wu et al., 2012; Tian et al., 2013). This initial network remodels to form a
more mature pattern comprising arteries and veins, with a number of small vessels initially
connecting to the aorta and coalescing to form two distinct ostia or openings (Ando et al.,
2004; Pérez-Pomares and de la Pompa, 2011). In addition to the endothelial cells that form
the coronary plexus, smooth muscle cells derived from the proepicardium surround and
support the portion of the coronary artery that connects with the aorta, known as the
coronary stem (Gittenberger-de Groot et al., 1999; von Kodolitsch et al., 2004; Grieskamp et
al., 2011). Even though the overall progression of coronary vascular development has been
well documented (Riley and Smart, 2011), key gaps remain in our understanding of this
process, particularly with respect to the signaling cues that guide endothelial cell migration.
One signaling pathway that is important in endothelial cell biology is the bone morphogenic
protein (BMP) pathway. Endothelial cells express a range of BMPs, including BMPs 2, 4, 6,
and 7, as well as type 1 and 2 BMP receptors (Bobik, 2006). The effects of the BMPs on
endothelial cell function are highly context dependent, with a single BMP being capable of
signaling through multiple intracellular pathways. BMPs can stimulate cell migration,
angiogenesis, apoptosis, and proliferation in some settings yet inhibit proliferation and
apoptosis in others (Bobik, 2006; Wiley and Jin, 2011). The BMP signaling pathway is
complex and regulated at many different levels. One level of regulation is afforded by
extracellular BMP regulators such as chordin, noggin and BMPER (BMP-binding
endothelial cell precursor-derived regulator). Whereas most of these regulators behave as
either a repressor or inducer of BMP signaling, BMPER can act as both (Kelley et al., 2009).
In vivo, BMPER has pro-BMP roles in the mouse eye, kidney, and skeleton (Ikeya et al.,
2006); zebrafish gastrulation (Rentzsch et al., 2006) and axis formation (Moser et al., 2007);
and drosophila crossvein formation (Conley et al., 2000). However, BMPER has also been
attributed anti-BMP roles in mouse retinal vascularization (Conley et al., 2000; Moreno-
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Miralles et al., 2011) and Xenopus axis formation (Moser et al., 2003). In vitro, BMPER has
been ascribed a pro-BMP role and promotes sprouting and migration in human umbilical
vein endothelial cells (HUVECs) (Heinke et al., 2008).
Despite the well-documented effects of the BMP pathway on endothelial cell biology, its
role in coronary vascular development has yet to be demonstrated. Therefore, this study was
undertaken to explore the role that BMP and its extracellular regulator BMPER has on the
development of the coronary vasculature. We hypothesized that BMPER would regulate
BMP signaling to promote coronary vascular development and tested this theory using the
BMPER−/− embryo as our model system. Embryonic BMPER−/− hearts present with a range
of coronary anomalies, despite a normal initiation of coronary plexus formation. Further,
endothelial apoptosis and subsequent contributions from the proepicardium appear normal in
the BMPER−/− hearts when compared with wild-type hearts. Analysis of ventricular
endothelial cells isolated during coronary vascular remodeling reveal that BMPER−/−
endothelial cells have impaired migration and remodeling abilities compared with their wild-
type counterparts. In addition, recombinant BMPER promotes wild-type ventricular
endothelial migration in a dose-dependent manner, with a low concentration promoting and
high concentrations inhibiting migration. Together, these results indicate that BMPER-
induced BMP signaling promotes normal coronary vascular development and that BMP
signaling is critical for normal coronary stem formation.
Materials and Methods
Mice
The creation of the BMPER−/− mouse was previously described (Kelley et al., 2009). Mice
were maintained on a C57BL/6N/129 background. Because the BMPER−/− embryo exhibits
perinatal lethality (Kelley et al., 2009), timed matings were performed using BMPER+/−
mice. All experiments were approved by the Institutional Animal Care and Use Committee
at the University of North Carolina at Chapel Hill. Based on the frequency of the coronary
defects, eight BMPER−/− embryos were required for each experiment that compared wild-
type and BMPER−/− embryos to have sufficient statistical power (power calculations: α =
0.05, 95% confidence, size effect = 0.67 based on coronary defects). Thus, the in vivo
quantitative analyses have a minimum of eight embryos per group.
Histology
For immunohistochemical analyses, E12.5-E16.5 embryos were harvested in phosphate-
buffered saline (PBS), fixed in 4% formaldehyde overnight at 4°C, washed in PBS, and
processed for paraffin or frozen sectioning, performed by the Histology Research Core
Facility at UNC. Additional hearts were harvested and utilized for whole-mount
immunohistochemistry. Unless indicated, immunohistochemistry was performed as
previously described (Waldo et al., 1996). Primary antibodies included MF-20
(Developmental Studies Hybridoma Bank, Iowa City, IA, USA), PECAM (Becton-
Dickinson, San Jose, CA, USA), phospho-Smad1, 5, 8 (pSmad; Cell Signaling Technology,
Danvers, MA, USA), phospho-Erk1/2 (Cell Signaling Technology), anti-Crossveinless-2
(also known as BMPER, R&D Systems, Minneapolis, MN, USA), and α-smooth muscle
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actin (Sigma-Aldrich, St. Louis, MO, USA). Primary antibodies were detected using
species-specific Alexa Fluor antibodies (Invitrogen, Grand Island, NY, USA) or ABC Elite
kits and diaminobenzidine (Vector Labs, Burlingame, CA, USA). pSmad and pERK
immunohistochemistry was performed as described in Dyer et al. (2010) with the addition of
1% BSA to the block solution for pERK, and BMPER immunohistochemistry was
performed as previously described (Zakin et al., 2008). For whole-mount confocal
microscopy, hearts were dehydrated and cleared with methyl salicylate prior to visualization.
In situ hybridization
The Tbx18 probe was kindly provided by Dr. Andreas Kispert (Medizinische Hochschule
Hannover, Germany). In brief, embryos were collected and processed for frozen sectioning
under RNase-free conditions. In situ hybridization was performed on 5-μm sections by the
In Situ Hybridization Core Facility at UNC.
Microscopy and image processing
All microscopy was performed in conjunction with the Microscope Services Laboratory at
UNC. Sections were imaged using an Olympus BX61 upright fluorescence microscope, and
whole hearts were imaged using a Zeiss LSM5 Pascal confocal laser scanning microscope
for fluorescently labeled hearts or a Leica-Wild M420 Macroscope for diaminobenzidine-
labeled hearts. Live cell imaging was performed using an Olympus IX70 inverted
fluorescence microscope that was fitted with a humidified, temperature-controlled chamber
that was maintained at 5% CO2. Volocity software was used to obtain all images. Static
images were processed using Adobe Photoshop, and confocal image stacks were processed
with Imaris. To compare phosphorylated protein expression, all acquisition parameters were
identical when photographing the slides and processing the images to ensure that any
differences in expression levels were real. Fluorescence intensity was assessed using the
histogram tool, and the intensity in the BMPER−/− embryos was assessed as the fold change
with respect to the average intensity of the wild-type embryos in each individual litter to
account for inter-litter variability and to minimize other processing-related variables, such as
time between immunohistochemistry and visualization.
Immunoblots
The aortic valves of E13.5 and E14.5 wild-type and BMPER−/− embryos were excised,
harvested in ice-cold lysis buffer containing phosphatase inhibitors, and and homogenized
using TissueLyser LT (Qiagen, Valencia, CA) (Meng et al., 2008). Each sample comprises
four individual valves. Membranes were blotted for pSmad and β-actin as a loading control.
Band density was quantified in ImageJ (www.nih.gov) and is presented as the percentage of
the wild-type pSmad/β-actin ratio.
Endothelial cell isolation
Endothelial cells were isolated from the ventricles of embryonic day 14.5-16.5 mice as
recently described (Dyer and Patterson, 2013a). In brief, ventricles were isolated from the
embryos, minced gently, and digested in collagenase type I for 45 minutes at 37°C with
gentle agitation. The resulting cell suspension was washed twice in DMEM (Gibco, Grand
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Island, NY, USA) containing 10% fetal bovine serum (FBS, Sigma-Aldrich) prior to an
incubation with anti-PECAM-conjugated Dynabeads (Invitrogen), prepared according to the
manufacturer’s recommendations. PECAM is expressed by both coronary endothelial cells
and endocardial cells. However, contributions from the ventricular endocardium to the
coronary endothelium primarily occur at E11.5, with endocardial migration decreasing
dramatically thereafter (Zhang and Zhou, 2013); thus, all migratory cells at the assessed time
points are considered coronary endothelial cells, and all samples should be similarly affected
by non-migratory endocardial cells. After a 30 minute incubation at 4°C, the bead-cell
solution was washed five times with 10% FBS-DMEM and once with DMEM prior to
dissociating the cells from the beads using trypsin-EDTA (Gibco). The resulting cells were
pelleted and resuspended as follows. For live cell imaging of the tube formation assay, cells
were resuspended in endothelial cell growth medium (ECGM) (DMEM containing 20%
FBS, 5 μM β-mercaptoethanol, 50 μg/ml ECG (Biomedical Technologies, Inc., Stoughton,
MA, USA), and penicillin/streptomycin) and plated on collagen-coated plates. Plates were
prepared as described in Runyan and Markwald (1983); all endothelial cells remained on the
surface of this collagen gel and preferred migrating on this collagen gel compared with a
simple coat of collagen (Dyer and Patterson). The number of cells per well was counted
after plating to ensure that similar numbers of cells were analyzed. For transwell assays,
endothelial cells were resuspended in DMEM and placed in the upper chamber of a
transwell (Corning, 8.0 μm pore size, polycarbonate membrane).
Endothelial cell analysis – tube formation assay
Approximately 24 hours after plating, isolated endothelial cells were incubated with the
fluorescent marker Syto-16 (Invitrogen), which is highly enriched in endothelial cells
(Arima et al., 2011). After 1 hour, the medium was replaced with fresh ECGM, and time-
lapse photography was performed. Isolated cells were maintained in a humidified chamber
at 37°C with 5% CO2 and were imaged every 15 minutes for 22 hours. The resulting movies
were analyzed with the MTrack plugin (Meijering et al.) for ImageJ (rsbweb.nih.gov/ij/).
The following parameters were analyzed: migration distance, cell-cell interactions, chain
length, and chain branching. For migration distance, the five most motile cells per sample
were tracked. Embryos were not genotyped until the analyses were complete to prevent
biasing the results.
Endothelial cell analysis – transwell migration assay
For transwell migration analysis, wild-type isolated endothelial cells were resuspended in
DMEM (approximately 2,000 cells per 75 μl DMEM). DMEM (500 μl) was added to the
lower chamber, and the cells were given one hour at 37°C to settle. Vehicle control or
recombinant BMPER (10-75 ng/ml) was added to the lower chamber, and endothelial cells
were allowed to migrate for four hours at 37°C. VEGF was used as a positive control. After
4 hours, the upper chamber side of the membrane was swabbed gently with a cotton-tipped
applicator, and the membranes were incubated in 0.1% crystal violet for 1 hour
(Mandelboim, 2006). The membranes were thoroughly washed with distilled water, and 4
10x images were obtained for each membrane. For each experiment, equal cell numbers
were plated in controls and treated wells, and the results are presented as the fold change
compared with the control to account for slight variability between experiments.
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Ex vivo BMPER-conjugated bead treatments
Hearts were excised from E13.5 embryos and cultured as previously described (Dyer and
Patterson). Agarose beads were conjugated to BMPER (72 ng/μl) or vehicle control as
described in Bronner-Fraser (2008) and placed adjacent to the ventricles, tucked near the
outflow tract. Hearts were cultured ex vivo with beads for 24 hours. Hearts were then fixed,
the position of the bead was documented, and hearts were prepared for
immunohistochemistry for pSmad and PECAM to determine how BMP signaling and
endothelial recruitment were affected by exogenous BMPER.
Statistics
For the migratory data and fluorescent intensity comparisons, ANOVA and unpaired
Student’s t-tests with equal variances were performed in Excel. Results are presented as the
mean and s.e.m. For categorical data, comparisons were analyzed using Fisher’s exact test in
R. A p-value <0.05 was considered significant.
Results
BMPER is expressed in cardiac endothelial cells and endothelial cell derivatives
Because BMPER was discovered in endothelial cell precursors (Moser et al., 2003) and
BMPER mRNA is expressed in the zebrafish vasculature (Moser et al., 2007), we evaluated
BMPER protein expression in the murine heart using immunohistochemistry. At E12.5-
E14.5, BMPER was expressed in the outflow tract cushions and subsequent valve leaflets
but was not expressed within the overlying endothelial layer (Fig. 1A, B, D-H). BMPER
expression did not colocalize with the myocardium, and DAPI-positive, BMPER-negative
endocardial cells are observed in the outflow tract cushions (Fig. 1A). BMPER’s expression
in the endocardial cells lining the trabeculae (Fig. 1A) appears to correlate with PECAM
(Fig. 1B). Importantly, BMPER protein is not detected in BMPER−/− embryos (Fig. 1C).
BMPER-positive coronary vessels were observed at the base of the outflow tract
myocardium (Fig. 1D-F). Interestingly, the coronary arteries did not express BMPER during
insertion into the aorta (Fig. 1G, H), suggesting that BMPER must be downregulated in the
coronary endothelial cells prior to their connection with the aorta. The expression of
BMPER in a subset of coronary vessels prompted us to examine whether BMPER plays a
role in coronary plexus development.
Coronary plexus formation begins normally in the BMPER−/− embryo
Because BMPER and the BMP signaling pathway have been linked to the development of
vascular networks in other models (Moser et al., 2007; Moreno-Miralles et al., 2011; Pi et
al., 2012), coronary plexus development was examined in wild-type and BMPER−/− hearts
to determine whether BMPER is important for the development of the coronary plexus.
Whole mount immunohistochemical analysis of wild-type and BMPER−/− hearts at E14.5
showed that PECAM-positive endothelial cells completely encompassed the ventricles from
sinus venosus to apex (Fig. 2A, C, E) and were found within the compact myocardium of
both wild-type and BMPER−/− ventricles (Fig. 2B, D, F). Based on the whole mount
immunohistochemistry, an analysis of the percentage of the heart encompassed by the
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forming plexus, the number of sprouts along the leading edge of the plexus, and the branch
points within the plexus showed no differences between genotypes (Fig. 2G-I; see also
Supplemental Fig. 1 for additional stages and details showing the measured parameters).
Thus, coronary plexus formation occurs normally in the BMPER−/− embryo.
Coronary stem formation is disrupted in the BMPER−/− embryo
By E15.5, the coronary vasculature should be connected to the aorta via two distinct
coronary ostia. Whole mount confocal analysis of wild-type hearts between E15.5 and E17.5
demonstrated normal connection of the coronary arteries to the aorta, with the coronary
arteries connecting to the aorta below the semilunar valve, at the level of the myocardium
(Fig. 3A-E). However, analysis of BMPER−/− embryos at these stages of development
revealed varying degrees of malformation of the coronary stems. In some BMPER−/−
embryos (n=5 of 18), the coronary stems connected high above the semilunar valve, known
as a “high take-off coronary” (compare Fig. 3I with Fig. 3B). In such cases, the high take-off
coronary was observed up to 200 μm above the semilunar valve, and the other coronary stem
was typically in the correct location (Fig. 3H, I). In other BMPER−/− embryos, vessels were
observed within the myocardium and even the subepicardial space, but these vessels failed
to connect to the aorta (n=9 of 18; Supplemental Fig. 2). These defects were consistently
observed in BMPER−/− embryos; only rarely was a coronary anomaly observed in wild-type
embryos (n=1 of 11 wild-type hearts; p<0.001).
Because the C57BL/6N mouse strain is prone to high take-off and atretic coronaries
(Fernandez et al., 2008), we compared the prevalence of defects in our mice to the reported
prevalence of coronary anomalies in pure C57BL/6N mice, and coronary atresia was
significantly more prevalent (p<0.01) in our BMPER−/− embryos on the mixed background.
Thus, the presence of the C57BL/6N background in our mixed background does not explain
the BMPER−/− phenotype.
Coronary artery smooth muscle recruitment is not impaired in BMPER−/− embryos
A final step in coronary stem formation is the addition of proepicardial-derived smooth
muscle cells, which stabilize the coronary stems (Gittenberger-de Groot et al., 1999).
Because BMP signaling promotes proepicardial addition (Schlueter et al., 2006; Ishii et al.,
2010), BMPER expression was analyzed in the proepicardium at E9.5 to determine whether
BMPER also affects proepicardial derivatives. BMPER expression did not colocalize with
the proepicardial marker Tbx18, indicating that BMPER cannot directly regulate
proepicardial addition (Supplemental Fig. 3A, B). Further, smooth muscle cells were
recruited to the coronary stems by E15.5 in BMPER−/− embryos, as observed in wild-type
embryos, indicating that proepicardial derivatives are correctly formed in the absence of
BMPER (Supplemental Fig. 3C, D). Together, these data indicate that BMPER does not
affect the proepicardium or its derivatives.
BMPER−/− coronary endothelial cells do not undergo abnormal proliferation or apoptosis
We next examined wild-type and BMPER−/− hearts to determine whether differences in
endothelial cell proliferation or apoptosis may be a potential mechanism responsible for the
coronary stem defects seen in the BMPER−/− hearts, given BMP’s role in regulating
Dyer et al. Page 7






















endothelial proliferation and apoptosis. In E12.5-E16.5 wild-type and BMPER−/− hearts,
apoptotic endothelial cells were rarely observed throughout the compact myocardium or
specifically in the coronary stems, and no differences were observed between genotypes
(Supplemental Fig. 4A-C). In addition, no difference in endothelial cell proliferation was
observed between wild-type and BMPER−/− hearts between E13.5 and E16.5 (Supplemental
Fig. 4D-F). Together, these data indicate that endothelial cell survival and proliferation are
not responsible for the observed coronary defects seen in BMPER−/− hearts.
BMPER is required in a cell autonomous manner for coronary endothelial migration
Based on BMPER’s expression pattern in the developing coronary vasculature and the
outflow tract cushions, we hypothesized that BMPER may directly promote coronary
endothelial migration or that BMPER may serve as a guidance cue to recruit coronary
endothelial cells to the aorta at the level of the aortic valve. Thus, we first performed in vitro
assays to determine the effect of BMPER specifically on coronary endothelial migration and
tubulogenesis. Although siRNA is commonly used to assess the effects of gene knockdown
in cell culture, siRNA knockdown techniques are typically not 100% efficient (Dennstedt
and Bryan, 2011). BMPER’s effects on BMP signaling appear to be concentration-
dependent (Kelley et al., 2009), so a partial siRNA knockdown may have unintended
consequences. Thus, to truly assess the effects of the absence of BMPER on endothelial
cells, wild-type and BMPER−/− endothelial cells were isolated from the ventricles of
E14.5-16.5 embryos. These isolated cells labeled positively with the endothelial markers
isolectin, PECAM, Flk-1, and Syto-16 (Fig. 5A and Dyer and Patterson), confirming the
identity of the isolated cells as endothelial cells and not supporting mural cells (Arima et al.,
2011). Isolated endothelial cells were plated on a collagen gel and allowed to adhere for 24
hours prior to live-cell imaging. Due to the limited number of primary cells obtained,
traditional tubulogenesis assays were not possible. Instead, a 22-h live-cell imaging period
was used to document the cells’ behavior. Wild-type endothelial cells migrated robustly,
forming cell-cell contacts that often led to chains with some branching (Fig. 4B, C). In
contrast, BMPER−/− endothelial cells migrated shorter distances and tended to make fewer
cell-cell contacts, which led to shorter chains with little to no branching (Fig. 4B, C).
Further, BMPER+/− endothelial cells also display significantly reduced migration and fewer
branches compared with wild-type endothelial cells (Fig. 4B, C). These experiments
demonstrate that a specific dose of BMPER is required by ventricular endothelial cells for
migration and remodeling.
BMPER promotes canonical BMP signaling in the aortic valve
BMPER’s robust expression in the developing outflow tract cushions during coronary artery
recruitment suggested that BMPER-mediated BMP signaling may affect coronary artery
recruitment by recruiting the coronary arteries to the aortic valve. Thus, pSmad expression
levels were examined in the valves at E13.5-E14.5. These specific stages were examined
because the coronary stems are present by E14.0 (Compton et al., 2007). At E13.5, Smad
was phosphorylated in the valves of wild-type embryos (Fig. 5A), whereas BMPER−/−
embryos appeared reduced Smad phosphorylation levels (Fig. 5B). At E14.5, Smad
phosphorylation remained high in the wild-type valves (Fig. 5C) and reduced in the
BMPER−/− valves (Fig. 5D). These differences were confirmed by performing immunoblot.
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The aortic valve, together with the surrounding aortic wall, was dissected from E13.5 and
E14.5 wild-type and BMPER−/− embryos, and four embryos were pooled per sample.
Compared with the wild-type valves, Smad phosphorylation levels were down-regulated in
the BMPER−/− valves at both time points (Fig. 5E, F). By comparison, Smad
phosphorylation in the valve sinus endothelium was slightly reduced in the BMPER−/−
embryos at both E13.5 and E14.5 compared with wild-type embryos, but this difference was
not significant. Thus, the specific downregulation of Smad phosphorylation specifically
within the BMPER−/− aortic valve may be associated with the coronary artery insertion
defects.
Although BMP signaling is most often associated with activation of Smad, BMPs can also
lead to ERK1/2 phosphorylation (Derynck and Zhang, 2003). Therefore, ERK1/2
phosphorylation in the cardiac valves was also compared between wild-type and BMPER−/−
hearts at E13.5-E14.5. However, at these stages of development, ERK1/2 phosphorylation
was limited to the mesenchymal cells underlying the tips of the valves in both wild-type and
BMPER−/− embryonic hearts (Supplemental Fig. 5). Thus, based on the discrete localization
of ERK1/2 phosphorylation, these results suggest that ERK1/2 signaling does not affect
coronary stem location.
BMPER may directly recruit coronary endothelial cells
Because BMPER is expressed in the aortic valve, at the level where the coronary arteries are
recruited to the aorta (Fig. 1), where it promotes canonical BMP signaling (Fig. 5), we
evaluated whether BMPER could recruit coronary vessels in an ex vivo culture system.
Wild-type and BMPER−/− E13.5 hearts were excised and cultured in the presence of
BMPER- or vehicle control-conjugated agarose beads. Smad phosphorylation appeared to be
upregulated in cells adjacent to BMPER-conjugated beads in the BMPER−/− hearts
compared with control beads (Fig. 6A). Further, the control beads appeared to have no effect
on Smad phosphorylation in both genotypes, and Smad phosphorylation appeared
downregulated in the BMPER−/− hearts with control beads compared with the wild-type
counterparts, consistent with Fig. 4. Consistent with a pro-angiogenic role, BMPER-
conjugated beads recruited PECAM-positive endothelial cells in both wild-type and
BMPER−/− hearts (Fig. 6B).
To determine whether BMPER directly promotes endothelial migration, wild-type
endothelial cells from E13.5-16.5 hearts were used for transwell assays. BMPER doses were
based on previous work showing that BMPER can promote HUVEC migration (Heinke et
al., 2008), and VEGF was used as a positive control (Fig. 6C). Compared with vehicle
control, the lowest dose of BMPER (10 ng/ml) significantly increased endothelial migration
1.6-fold over a 4-hour period (Fig. 6D). Higher doses of BMPER (20-75 ng/ml) decreased
endothelial migration by one-third compared with the vehicle control. This dose response
suggests that a low dose of BMPER can directly promote endothelial migration whereas
higher doses halt migration.
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The coronary vasculature is essential for late embryonic development and post-natal life.
However, whereas early stages of coronary vascular development have been well described
(Riley and Smart, 2011), the crucial connection of the coronary plexus to the aorta remains
poorly understood. In the mouse in particular, the process through which the stems are
formed within the aorta has not been clearly documented. This study takes advantage of the
BMPER−/− mouse model by beginning to unravel the distinct steps required for normal
coronary stem development. The BMPER−/− mouse, which does not display early coronary
plexus defects, provides a unique opportunity to address the signaling events required to
recruit the coronary arteries to the aorta.
The BMP pathway has many known roles in endothelial cells, where it can promote
endothelial cell migration, proliferation, and apoptosis (Wiley and Jin, 2011). Some of these
specific roles have been attributed to individual BMPs and particular intracellular pathways.
Specifically examining endothelial migration, BMP2 can induce endothelial remodeling via
p38/MAPK, through which it modulates transcription factor Id1 (Raida et al., 2005), and
possibly via ERK1/2, though current studies are contradictory (Langenfeld and Langenfeld,
2004; Raida et al., 2005). BMP4 can promote endothelial migration via both the Smad and
ERK intracellular pathways (Heinke et al., 2008) and apoptosis through the Smad and
possibly Msx1/2 intracellular pathways (Kiyono and Shibuya, 2003). BMP6 can also
promote endothelial migration via Id1 (Valdimarsdottir et al., 2002). Importantly within the
context of coronary stem formation, BMPs 2, 4, and 6 are expressed either within the
myocardium at the base of the aorta or in the aortic endothelium and aortic valve leaflets
during the establishment of the coronary plexus and its subsequent connection with the aorta
(Kim et al., 2001; Jiao et al., 2003; Keyes et al., 2003; Liu et al., 2004; Danesh et al., 2009;
Jang et al., 2010). BMPER shows a similar expression pattern, with expression within the
endothelial cells surrounding the outflow tract and within the endothelially derived aortic
valve mesenchyme. Thus, BMPER is spatiotemporally located in a manner to regulate the
BMPs that are being expressed. Further, the dose-response migration data (Fig. 6D) suggest
that increasing concentrations of BMPER switch its role from acting as a pro-migratory
factor to an anti-migratory factor. A quantitative assessment of the concentration of BMPER
throughout the developing heart would be interesting in that it may determine whether
BMPER’s expression level correlates with the dose-response migration data. However,
without a reliable readout, for example, one that is comparable to using Smad
phosphorylation to assess canonical BMP signaling, this experiment is not yet feasible.
Based on the expression of BMPs and BMPER and the known roles of BMP signaling in
endothelial behavior, the observed coronary stem defects are not unexpected. However,
coronary remodeling is poorly studied. Endothelial cells are so heterogeneous that it is
difficult to translate results from one specific endothelial cell population to another (Dyer
and Patterson, 2010), and embryonic coronary endothelial cells are not currently
commercially available. To further complicate the study of BMPER in this population of
cells, BMPER itself shows a dose-dependent biphasic effect (Fig. 6 and Kelley et al., 2009),
rendering a partial siRNA knockdown model inadequate to address what happens in the
absence of BMPER. To truly analyze coronary endothelial remodeling in vitro, specifically
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in the absence of BMPER, coronary endothelial cells from the BMPER−/− embryo is the
ideal model.
Thus, we down-scaled well-established protocols for endothelial cell isolation and applied
them to the developing heart (Dyer and Patterson). Preferably, these experiments would be
performed using cells isolated just prior to connection of the coronary vasculature to the
aorta; however, the yield of endothelial cells obtained from such small hearts was
insufficient to perform the desired analyses, even with the down-scaled assay we employed.
Instead, we utilized endothelial cells obtained from the hearts of E14.5-16.5 embryos; these
stages include the coronary remodeling period (Lavine and Ornitz, 2009). Using this
approach, we determined that coronary endothelial cells require BMPER to migrate. Cells
isolated from BMPER−/− ventricles migrated less than their wild-type counterparts, and the
subsequent observations of shorter chains and less branching may be directly caused by this
impairment. Interestingly, though, BMPER is not expressed in the coronary endothelial cells
as the coronary arteries connect with the aorta (Fig. 1G, H), suggesting that BMPER plays
an earlier role in the endothelial cell that promotes migration. This early role is supported by
the in vitro coronary endothelial migration data. However, we believe that BMPER also has
an indirect role in this process. The dose-dependent responses observed in the transwell
migration assays suggest that wild-type coronary endothelial cells migrate in response to a
low dose of BMPER but then stop migrating in response to high doses of BMPER. In the
aortic valve, BMPER may affect additional signaling pathways that enhance coronary artery
recruitment, leading to an even stronger effect than observed in our transwell assays. These
findings may explain why coronary plexus formation can begin normally in the BMPER−/−
ventricles but then remodels incorrectly, leading to defects in coronary stem formation. In
addition, these findings may explain how the BMPER−/− embryo exhibits both atretic
coronary stems, which may be due to a failure of the coronary endothelial cells to migrate
enough to reach the aorta and/or a failure to detect the aortic valve, and high take-off
coronary arteries, which may represent a simple failure of the coronary endothelial cells to
detect the aortic valve. This hypothesis is further supported by the BMPER+/− embryo,
which does not display coronary artery anomalies (data not shown) despite impaired
endothelial cell migration (Figure 5).
We have established that Smad-dependent BMP signaling is upregulated in the aortic valves
when the coronary arteries should connect to the aorta and that BMPER is required for this
activity. Further, BMPER is required specifically within the coronary endothelial cells and
promotes migration and remodeling, as shown using isolated embryonic coronary
endothelial cells. This study opens up an innovative tactic for examining coronary plexus
formation and remodeling and the intrinsic and extrinsic factors that regulate these
processes.
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Refer to Web version on PubMed Central for supplementary material.
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*The BMPER−/− embryo displays coronary stem defects in the absence of global
coronary plexus defects.
*BMPER mediates coronary stem placement in the aorta.
*BMPER promotes coronary endothelial migration.
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Figure 1. BMPER is expressed in the endothelium and outflow tract cushions
Immunohistochemistry in saggital (A, B, D-F) and cross-sections (C, G, H) of E12.5 (A, B),
E13.5 (D, F, G) and E14.5 (E, H) wild-type embryos and (C) an E13.5 BMPER−/− embryo
demonstrates that BMPER expression is restricted to the outflow tract cushions and some
endothelial cells during outflow tract septation and coronary artery recruitment. (A, B)
BMPER (black) does not colocalize with myocardial marker MF20 (red, A), is excluded
from the endocardial cells overlying the cushions (A), and shows a similar pattern in the
ventricle as endothelial marker PECAM (green, B). (C) BMPER is not detected in the aortic
valve of an E13.5 BMPER−/− embryo, highlighting the fidelity of the antibody. (D, E) Low
magnification images of the outflow tract of wild-type E13.5 (D) and E14.5 (E) embryos,
including aorta (Ao) and pulmonary artery. (F-H) Higher magnification images highlight a
BMPER-positive coronary vessel in the compact myocardium (arrowhead, F) and BMPER
expression in the aortic valve at E13.5 (G) and E14.5 (H); arrows indicate coronary stems.
Ao, aorta; RV, right ventricle; PA, pulmonary artery; CA, coronary artery. Blue, DAPI.
Scale bar in A-E, 100 μm; scale bar in F, 25 μm; scale bar in G-H, 50 μm.
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Figure 2. The coronary plexus begins to form in the absence of BMPER
Whole mount immunohistochemistry in E14.5 wild-type (A) and BMPER−/−(B) hearts
shows that endothelial cells (black) encompass the dorsal aspect of the ventricles and cover
the ventricles by E14.5. Immunohistochemistry of sagittal sections of wild-type (C, E) and
BMPER−/− (D, F) hearts at E14.5 shows that this vasculature permeates the compact
myocardium. Shown are low magnification (C, D) and higher magnification (E, F) images
of the left ventricle (LV) at the level of the mitral valve. Green, endothelium; blue, nuclei.
To ensure that the vascular plexus developed normally in BMPER−/− embryos, the
following measurements were compared in whole mount PECAM-labeled E14.5 hearts: the
percentage of surface area encompassed by the plexus (G), the number of branch points (H),
and the number of sprouts in the leading edge of the plexus (I). No differences were oberved
between genotypes. Scale bar in A, B, 500 μm; scale bar in C, D, 100 μm; scale bar in E, F,
50 μm. Li, liver.
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Figure 3. BMPER−/− embryos exhibit coronary stem defects
Whole mount confocal imaging of E17.5 wild-type (A-D) and BMPER−/− (F-I) hearts
through the aorta shows the connection of the coronary arteries in a wild-type heart (arrows
in A-D, depicted schematically in E) and in a BMPER−/− heart (arrows in F-I, depicted
schematically in J). In the BMPER−/− hearts, the coronary arteries either connect above the
semilunar valve (arrow in H and I; n=4 of 13 embryos) or fail to form stems at all (n=7 of 13
embryos, Supplemental Fig. 1). These defects are rarely observed in wild-type embryos (n=1
of 9 embryos; p<0.01). (E, I) Schematics depicting the insertion of the coronary artery in the
aortic sinuses; the schematic design is based on Clauss et al. (2006). Green, endothelium;
red, myocardium. Ao, aorta. Scale bar, 150 μm.
Dyer et al. Page 18






















Figure 4. Migration is impaired in isolated BMPER−/− ventricular endothelial cells
(A) Endothelial cells were isolated from E14.5-E16.5 wild-type (WT, n=3), BMPER+/−
(n=10), and BMPER−/− (n=3) ventricles with PECAM-conjugated beads. Wild-type isolated
endothelial cells were positively labeled with lectin (red). Scale bar, 50 μm. After 24 hours
of culture, isolated endothelial cells were labeled with Syto-16 and photographed over a 20-
h period. Compared with wild-type endothelial cells (black bars), BMPER+/− (grey bars) and
BMPER−/− (white bars) endothelial cells migrated less (B) and tended to create fewer cell-
cell connections (p=0.1, ANOVA) and branches (p<0.05, ANOVA) and shorter chains
(measured as the number of cells per chain, p<0.1, ANOVA) (C). *p<0.05, **p<0.01;
Student’s t-test.
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Figure 5. Canonical BMP activity is downregulated in BMPER−/− aortic valves
Compared with wild-type aortic valves (A, C), BMP activity, as indicated by phosphorylated
Smad1, 5, 8 expression (pSmad, green), is downregulated in BMPER−/− aortic valves at
E13.5 (B) and E14.5 (D). (E) The pSmad levels were quantified in aortic valves dissected
from E13.5 and E14.5 wild-type and BMPER−/− embryos. Four valves were pooled in each
lane, and pSmad band density, normalized to β-actin, is quantified in (F) as the % of the age-
matched wild-type sample. Red, endothelium, labeled with lectin. Arrows, aortic sinuses;
arrowheads, coronary stems. Ao, aorta. Scale bar, 70 μm.
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Figure 6. BMPER indirectly promotes ventricular endothelial cell migration
(A, B) Wild-type and BMPER−/− E13.5 hearts were cultured ex vivo with vehichle control-
or BMPER-conjugated beads. (A) Smad phosphorylation was assessed after 24 hours of
culture. pSmad signaling intensity was stronger in the cells adjacent to BMPER-conjugated
beads compared with control beads and was similarly stronger in wild-type compared with
BMPER−/− hearts. (B) Endothelial migration was also assessed after 24 hours of culture
using the endothelial marker PECAM. PECAM-positive vessels were more closely
associated with BMPER-conjugated beads than with control beads. The small number of
BMPER−/− hearts cultured with control beads precluded statistical analyses in this
experiment. n=6 wild-type + control bead, 9 wild-type + BMPER bead, 2 BMPER−/− +
control bead, 4 BMPER−/− + BMPER bead. Scale bars, 120 μm. (C, D) Isolated wild-type
endothelial cells (E13.5-16.5) were subjected to transwell migration assays using (C) VEGF
(25 ng/ml) and its vehicle control (0.1% BSA in 4 mM HCl) and (D) BMPER and its vehicle
control (0.5% BSA in PBS). As expected, VEGF induced a nearly three-fold increase in
migration compared with the vehicle control. In contrast, a low dose of BMPER (10 ng/ml)
induced endothelial migration (1.6-fold over the control level of migration), whereas higher
doses of BMPER (20-75 ng/ml) inhibited migration. *p<0.05 vs. control; n=3-7 transwells
per condition.
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